WEKO3
アイテム
{"_buckets": {"deposit": "c8927f19-e390-4bd1-9e79-0aced1fd1e2b"}, "_deposit": {"created_by": 2, "id": "1200", "owners": [2], "pid": {"revision_id": 0, "type": "depid", "value": "1200"}, "status": "published"}, "_oai": {"id": "oai:nagasaki-u.repo.nii.ac.jp:00001200", "sets": ["9"]}, "author_link": ["5619", "5616", "5620", "5621", "5625", "5614", "5622", "5618", "5615", "5623", "5624", "5617"], "item_2_biblio_info_6": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2018-04", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "4", "bibliographicPageStart": "01971-17", "bibliographicVolumeNumber": "62", "bibliographic_titles": [{"bibliographic_title": "Antimicrobial Agents and Chemotherapy"}]}]}, "item_2_description_4": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Lascufloxacin showed potent activity against Streptococcus pneumoniae with a GyrA or ParC mutation (first-step mutant). The frequency of selecting resistant strains tended to be lower for lascufloxacin than for levofloxacin and garenoxacin after drug exposure in first-step mutants but was similar in the comparison between lascufloxacin and moxifloxacin. The increase in MIC was smaller for lascufloxacin than for levofloxacin, garenoxacin, and moxifloxacin when clinical strains with only ParC mutations were exposed to the corresponding drug.", "subitem_description_type": "Abstract"}]}, "item_2_description_63": {"attribute_name": "引用", "attribute_value_mlt": [{"subitem_description": "Antimicrobial Agents and Chemotherapy, 62(4), 01971-17; 2018", "subitem_description_type": "Other"}]}, "item_2_publisher_33": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "American Society for Microbiology"}]}, "item_2_relation_12": {"attribute_name": "DOI", "attribute_value_mlt": [{"subitem_relation_type": "isVersionOf", "subitem_relation_type_id": {"subitem_relation_type_id_text": "10.1128/AAC.01971-17", "subitem_relation_type_select": "DOI"}}]}, "item_2_rights_13": {"attribute_name": "権利", "attribute_value_mlt": [{"subitem_rights": "c Copyright 2018 American Society for Microbiology. All Rights Reserved."}]}, "item_2_source_id_7": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "00664804", "subitem_source_identifier_type": "ISSN"}]}, "item_2_source_id_8": {"attribute_name": "EISSN", "attribute_value_mlt": [{"subitem_source_identifier": "10986596", "subitem_source_identifier_type": "ISSN"}]}, "item_2_version_type_16": {"attribute_name": "著者版フラグ", "attribute_value_mlt": [{"subitem_version_resource": "http://purl.org/coar/version/c_ab4af688f83e57aa", "subitem_version_type": "AM"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Murata, Mika"}], "nameIdentifiers": [{"nameIdentifier": "5614", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kosai, Kosuke"}], "nameIdentifiers": [{"nameIdentifier": "5615", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Yamauchi, Shunsuke"}], "nameIdentifiers": [{"nameIdentifier": "5616", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Sasaki, Daisuke"}], "nameIdentifiers": [{"nameIdentifier": "5617", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kaku, Norihito"}], "nameIdentifiers": [{"nameIdentifier": "5618", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Uno, Naoki"}], "nameIdentifiers": [{"nameIdentifier": "5619", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Morinaga, Yoshitomo"}], "nameIdentifiers": [{"nameIdentifier": "5620", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Hasegawa, Hiroo"}], "nameIdentifiers": [{"nameIdentifier": "5621", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Miyazaki, Taiga"}], "nameIdentifiers": [{"nameIdentifier": "5622", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Izumikawa, Koichi"}], "nameIdentifiers": [{"nameIdentifier": "5623", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Mukae, Hiroshi"}], "nameIdentifiers": [{"nameIdentifier": "5624", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Yanagihara, Katsunori"}], "nameIdentifiers": [{"nameIdentifier": "5625", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2020-12-18"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "AAC62_1971-17.pdf", "filesize": [{"value": "145.3 kB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 145300.0, "url": {"label": "AAC62_1971-17.pdf", "url": "https://nagasaki-u.repo.nii.ac.jp/record/1200/files/AAC62_1971-17.pdf"}, "version_id": "e0c4bf77-db7a-4102-9a04-e6dd6fa5ca0b"}]}, "item_keyword": {"attribute_name": "キーワード", "attribute_value_mlt": [{"subitem_subject": "Fluoroquinolone resistance", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Lascufloxacin", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Streptococcus pneumoniae", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "In Vitro Activity of Lascufloxacin against Streptococcus pneumoniae with Mutations in the Quinolone Resistance-Determining Regions", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "In Vitro Activity of Lascufloxacin against Streptococcus pneumoniae with Mutations in the Quinolone Resistance-Determining Regions"}]}, "item_type_id": "2", "owner": "2", "path": ["9"], "permalink_uri": "http://hdl.handle.net/10069/38449", "pubdate": {"attribute_name": "公開日", "attribute_value": "2018-08-01"}, "publish_date": "2018-08-01", "publish_status": "0", "recid": "1200", "relation": {}, "relation_version_is_last": true, "title": ["In Vitro Activity of Lascufloxacin against Streptococcus pneumoniae with Mutations in the Quinolone Resistance-Determining Regions"], "weko_shared_id": -1}
In Vitro Activity of Lascufloxacin against Streptococcus pneumoniae with Mutations in the Quinolone Resistance-Determining Regions
http://hdl.handle.net/10069/38449
http://hdl.handle.net/10069/384497cfe263f-fd17-47de-812e-1512f3d5c845
名前 / ファイル | ライセンス | アクション |
---|---|---|
AAC62_1971-17.pdf (145.3 kB)
|
|
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2018-08-01 | |||||
タイトル | ||||||
タイトル | In Vitro Activity of Lascufloxacin against Streptococcus pneumoniae with Mutations in the Quinolone Resistance-Determining Regions | |||||
言語 | ||||||
言語 | eng | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | Fluoroquinolone resistance | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | Lascufloxacin | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | Streptococcus pneumoniae | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
著者 |
Murata, Mika
× Murata, Mika× Kosai, Kosuke× Yamauchi, Shunsuke× Sasaki, Daisuke× Kaku, Norihito× Uno, Naoki× Morinaga, Yoshitomo× Hasegawa, Hiroo× Miyazaki, Taiga× Izumikawa, Koichi× Mukae, Hiroshi× Yanagihara, Katsunori |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Lascufloxacin showed potent activity against Streptococcus pneumoniae with a GyrA or ParC mutation (first-step mutant). The frequency of selecting resistant strains tended to be lower for lascufloxacin than for levofloxacin and garenoxacin after drug exposure in first-step mutants but was similar in the comparison between lascufloxacin and moxifloxacin. The increase in MIC was smaller for lascufloxacin than for levofloxacin, garenoxacin, and moxifloxacin when clinical strains with only ParC mutations were exposed to the corresponding drug. | |||||
書誌情報 |
Antimicrobial Agents and Chemotherapy 巻 62, 号 4, p. 01971-17, 発行日 2018-04 |
|||||
出版者 | ||||||
出版者 | American Society for Microbiology | |||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 00664804 | |||||
EISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 10986596 | |||||
DOI | ||||||
関連タイプ | isVersionOf | |||||
識別子タイプ | DOI | |||||
関連識別子 | 10.1128/AAC.01971-17 | |||||
権利 | ||||||
権利情報 | c Copyright 2018 American Society for Microbiology. All Rights Reserved. | |||||
著者版フラグ | ||||||
出版タイプ | AM | |||||
出版タイプResource | http://purl.org/coar/version/c_ab4af688f83e57aa | |||||
引用 | ||||||
内容記述タイプ | Other | |||||
内容記述 | Antimicrobial Agents and Chemotherapy, 62(4), 01971-17; 2018 |